Cargando…

Aeromonas punctata derived depolymerase improves susceptibility of Klebsiella pneumoniae biofilm to gentamicin

BACKGROUND: To overcome antibiotic resistance in biofilms, enzymes aimed at biofilm dispersal are under investigation. In the present study, applicability of an Aeromonas punctata derived depolymerase capable of degrading the capsular polysaccharide (CPS) of Klebsiella pneumoniae, in disrupting its...

Descripción completa

Detalles Bibliográficos
Autores principales: Bansal, Shruti, Harjai, Kusum, Chhibber, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461996/
https://www.ncbi.nlm.nih.gov/pubmed/26063052
http://dx.doi.org/10.1186/s12866-015-0455-z
_version_ 1782375590565773312
author Bansal, Shruti
Harjai, Kusum
Chhibber, Sanjay
author_facet Bansal, Shruti
Harjai, Kusum
Chhibber, Sanjay
author_sort Bansal, Shruti
collection PubMed
description BACKGROUND: To overcome antibiotic resistance in biofilms, enzymes aimed at biofilm dispersal are under investigation. In the present study, applicability of an Aeromonas punctata derived depolymerase capable of degrading the capsular polysaccharide (CPS) of Klebsiella pneumoniae, in disrupting its biofilm and increasing gentamicin efficacy against biofilm was investigated. RESULTS: Intact biofilm of K. pneumoniae was recalcitrant to gentamicin due to lack of antibiotic penetration. On the other hand, gentamicin could not act on disrupted biofilm cells due to their presence in clusters. However, when depolymerase (20 units/ml) was used in combination with gentamicin (10 μg/ml), dispersal of CPS matrix by enzyme facilitated gentamicin penetration across biofilm. This resulted in significant reduction (p < 0.05) in bacterial count in intact and disrupted biofilms. Reduction in CPS after treatment with depolymerase was confirmed by confocal microscopy and enzyme linked lectinosorbent assay. Furthermore, to substantiate our study, the efficacy of bacterial depolymerase was compared with a phage borne depolymerase possessing similar application against K. pneumoniae. Although both were used at same concentration i.e. 20 units/ml, but a higher efficacy of bacterial depolymerase particularly against older biofilms was visibly clear over its phage counterpart. This could be explained due to high substrate affinity (indicated by K(m) value) and high turnover number (indicated by K(cat) value) of the bacterial depolymerase (K(m) = 89.88 μM, K(cat) = 285 s(−1)) over the phage derived one (K(m) = 150 μM, K(cat) = 107 s(−1)). CONCLUSION: Overall the study indicated that, the A. punctata derived depolymerase possesses antibiofilm potential and improves gentamicin efficacy against K. pneumoniae. Moreover, it can serve as a potential substitute to phage borne depolymerases for treating biofilms formed by K. pneumoniae. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12866-015-0455-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4461996
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44619962015-06-11 Aeromonas punctata derived depolymerase improves susceptibility of Klebsiella pneumoniae biofilm to gentamicin Bansal, Shruti Harjai, Kusum Chhibber, Sanjay BMC Microbiol Methodology Article BACKGROUND: To overcome antibiotic resistance in biofilms, enzymes aimed at biofilm dispersal are under investigation. In the present study, applicability of an Aeromonas punctata derived depolymerase capable of degrading the capsular polysaccharide (CPS) of Klebsiella pneumoniae, in disrupting its biofilm and increasing gentamicin efficacy against biofilm was investigated. RESULTS: Intact biofilm of K. pneumoniae was recalcitrant to gentamicin due to lack of antibiotic penetration. On the other hand, gentamicin could not act on disrupted biofilm cells due to their presence in clusters. However, when depolymerase (20 units/ml) was used in combination with gentamicin (10 μg/ml), dispersal of CPS matrix by enzyme facilitated gentamicin penetration across biofilm. This resulted in significant reduction (p < 0.05) in bacterial count in intact and disrupted biofilms. Reduction in CPS after treatment with depolymerase was confirmed by confocal microscopy and enzyme linked lectinosorbent assay. Furthermore, to substantiate our study, the efficacy of bacterial depolymerase was compared with a phage borne depolymerase possessing similar application against K. pneumoniae. Although both were used at same concentration i.e. 20 units/ml, but a higher efficacy of bacterial depolymerase particularly against older biofilms was visibly clear over its phage counterpart. This could be explained due to high substrate affinity (indicated by K(m) value) and high turnover number (indicated by K(cat) value) of the bacterial depolymerase (K(m) = 89.88 μM, K(cat) = 285 s(−1)) over the phage derived one (K(m) = 150 μM, K(cat) = 107 s(−1)). CONCLUSION: Overall the study indicated that, the A. punctata derived depolymerase possesses antibiofilm potential and improves gentamicin efficacy against K. pneumoniae. Moreover, it can serve as a potential substitute to phage borne depolymerases for treating biofilms formed by K. pneumoniae. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12866-015-0455-z) contains supplementary material, which is available to authorized users. BioMed Central 2015-06-11 /pmc/articles/PMC4461996/ /pubmed/26063052 http://dx.doi.org/10.1186/s12866-015-0455-z Text en © Bansal et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology Article
Bansal, Shruti
Harjai, Kusum
Chhibber, Sanjay
Aeromonas punctata derived depolymerase improves susceptibility of Klebsiella pneumoniae biofilm to gentamicin
title Aeromonas punctata derived depolymerase improves susceptibility of Klebsiella pneumoniae biofilm to gentamicin
title_full Aeromonas punctata derived depolymerase improves susceptibility of Klebsiella pneumoniae biofilm to gentamicin
title_fullStr Aeromonas punctata derived depolymerase improves susceptibility of Klebsiella pneumoniae biofilm to gentamicin
title_full_unstemmed Aeromonas punctata derived depolymerase improves susceptibility of Klebsiella pneumoniae biofilm to gentamicin
title_short Aeromonas punctata derived depolymerase improves susceptibility of Klebsiella pneumoniae biofilm to gentamicin
title_sort aeromonas punctata derived depolymerase improves susceptibility of klebsiella pneumoniae biofilm to gentamicin
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461996/
https://www.ncbi.nlm.nih.gov/pubmed/26063052
http://dx.doi.org/10.1186/s12866-015-0455-z
work_keys_str_mv AT bansalshruti aeromonaspunctataderiveddepolymeraseimprovessusceptibilityofklebsiellapneumoniaebiofilmtogentamicin
AT harjaikusum aeromonaspunctataderiveddepolymeraseimprovessusceptibilityofklebsiellapneumoniaebiofilmtogentamicin
AT chhibbersanjay aeromonaspunctataderiveddepolymeraseimprovessusceptibilityofklebsiellapneumoniaebiofilmtogentamicin